Status:
UNKNOWN
Detachable String Magnetically Controlled Capsule Endoscopy for Detecting High-risk Varices in Compensated Cirrhosis
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Beijing 302 Hospital
Sir Run Run Shaw Hospital
Conditions:
Compensated Cirrhosis
Gastroesophageal Varices Bleeding
Eligibility:
All Genders
18-75 years
Brief Summary
Gastroesophageal varices is a serious complication of compensated advanced chronic liver disease (cACLD). Primary prophylaxis to reduce the risk of variceal haemorrhage is recommended if high-risk var...
Detailed Description
The presence of gastroesophageal varices (GEV) is a common and serious complication of compensated advanced chronic liver disease (cACLD).1-3 GEV hemorrhage is associated with a six week mortality rat...
Eligibility Criteria
Inclusion
- age 18-75 years;
- confirmed cirrhosis based on liver biopsy or clinical findings;
- compensated cirrhosis;
- scheduled to undergo esophagogastroduodenoscopy;
- estimated survival time\> 24 months, and model for end-stage liver disease (MELD) score\< 19;
- with written informed consent.
Exclusion
- contradictions for capsule endoscopy;
- contradictions for standard magnetic resonance imaging examination such as the presence of surgical metallic devices;
- pregnancy or unknown pregnancy status.
Key Trial Info
Start Date :
November 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2022
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03749954
Start Date
November 9 2018
End Date
November 8 2022
Last Update
November 17 2020
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fifth Medical Center of PLA General Hospital
Beijing, Beijing Municipality, China
2
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
3
Guangdong Second Provincial General Hospital
Guangzhou, Guangdong, China
4
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China